Medicaid

The pharma trade group claims CMS exceeded its authority with the Medicare Part B pricing model.

New surveys show growing public backing for Medicare for All ahead of the 2026 midterms, though partisan divides and cost concerns remain.

AHA report says reimbursement gaps, workforce shortages, and policy changes are intensifying financial strain on rural hospitals.

HRSA identified 10 drugmakers and 21 drugs for its revised 340B rebate pilot, reviving debate over oversight, costs and provider access.

New CMS rules require hospitals to disclose more accurate pricing data, aiming to improve price comparisons and patient decision-making.

House Democrats propose reversing healthcare cuts, protecting vaccine access, lowering costs, and expanding coverage in the next Congress.

The payer group says growing use of AI-powered coding tools may be increasing hospital billing costs, while hospitals blame other factors.

While most of the drugs reviewed were priced below the international average, nearly as many were priced above it.